Kiyohiro Ando
6PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 27, 2023
DNA Ligase 4 Contributes to Cell Proliferation against DNA-PK Inhibition in MYCN-Amplified Neuroblastoma IMR32 Cells.Kiyohiro Ando, Yusuke Suenaga, Takehiko Kamijo
|Feb 25, 2023
The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN.Kiyohiro Ando, Akira Nakagawara
|Sep 02, 2022
Polycomb EZH1 regulates cell cycle/5-fluorouracil sensitivity of neuroblastoma cells in concert with MYCN.Yoshitaka Shinno, Hisanori Takenobu, Ryuichi P Sugino
|Nov 22, 2021
FGFR2 loss sensitizes MYCN-amplified neuroblastoma CHP134 cells to CHK1 inhibitor-induced apoptosis.Kiyohiro Ando, Miki Ohira, Ichiro Takada
|Jun 02, 2021
Acceleration or Brakes: Which Is Rational for Cell Cycle-Targeting Neuroblastoma Therapy?Kiyohiro Ando, Akira Nakagawara
|Oct 05, 2020
CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma.Kiyohiro Ando, Verna Cázares-Ordoñez, Makoto Makishima
Pageof 1
Frequent Collaborators
2 joint publications
Miki Ohira
2 joint publications
Takehiko Kamijo
1 joint publications
Hiroki Nagase
1 joint publications
Satoshi Wada
1 joint publications
Hisanori Takenobu
1 joint publications
Yuki Endo
1 joint publications
Kyosuke Mukae
1 joint publications
Dilibaerguli Shaliman
1 joint publications
Jesmin Akter
1 joint publications
Atsuko Nakazawa
